144 related articles for article (PubMed ID: 33248444)
1. A Case of Luscan-Lumish Syndrome: Possible Involvement of Enhanced GH Signaling.
Suda K; Fukuoka H; Iguchi G; Kanie K; Fujita Y; Odake Y; Matsumoto R; Bando H; Ito H; Takahashi M; Chihara K; Nagai H; Narumi S; Hasegawa T; Ogawa W; Takahashi Y
J Clin Endocrinol Metab; 2021 Mar; 106(3):718-723. PubMed ID: 33248444
[TBL] [Abstract][Full Text] [Related]
2. Clinical and genetic features of luscan-lumish syndrome associated with a novel de novo variant of
Zhang Y; Zhang H; Wu W; Wang D; Lv Y; Zhao D; Wang L; Liu Y; Zhang K
Front Genet; 2023; 14():1081391. PubMed ID: 36777730
[No Abstract] [Full Text] [Related]
3. Two novel cases expanding the phenotype of SETD2-related overgrowth syndrome.
van Rij MC; Hollink IHIM; Terhal PA; Kant SG; Ruivenkamp C; van Haeringen A; Kievit JA; van Belzen MJ
Am J Med Genet A; 2018 May; 176(5):1212-1215. PubMed ID: 29681085
[TBL] [Abstract][Full Text] [Related]
4. Genotype-phenotype correlation at codon 1740 of SETD2.
Rabin R; Radmanesh A; Glass IA; Dobyns WB; Aldinger KA; Shieh JT; Romoser S; Bombei H; Dowsett L; Trapane P; Bernat JA; Baker J; Mendelsohn NJ; Popp B; Siekmeyer M; Sorge I; Sansbury FH; Watts P; Foulds NC; Burton J; Hoganson G; Hurst JA; Menzies L; Osio D; Kerecuk L; Cobben JM; Jizi K; Jacquemont S; Bélanger SA; Löhner K; Veenstra-Knol HE; Lemmink HH; Keller-Ramey J; Wentzensen IM; Punj S; McWalter K; Lenberg J; Ellsworth KA; Radtke K; Akbarian S; Pappas J
Am J Med Genet A; 2020 Sep; 182(9):2037-2048. PubMed ID: 32710489
[TBL] [Abstract][Full Text] [Related]
5. Clinical Heterogeneity and Different Phenotypes in Patients with
Parra A; Rabin R; Pappas J; Pascual P; Cazalla M; Arias P; Gallego-Zazo N; Santana A; Arroyo I; Artigas M; Pachajoa H; Alanay Y; Akgun-Dogan O; Ruaud L; Couque N; Levy J; Porras-Hurtado GL; Santos-Simarro F; Ballesta-Martinez MJ; Guillén-Navarro E; Muñoz-Hernández H; Nevado J; Spanish OverGrowth Registry Initiative ; Tenorio-Castano J; Lapunzina P
Genes (Basel); 2023 May; 14(6):. PubMed ID: 37372360
[TBL] [Abstract][Full Text] [Related]
6. A novel
Wu Y; Liu F; Wan R; Jiao B
Front Genet; 2023; 14():1153284. PubMed ID: 37025455
[No Abstract] [Full Text] [Related]
7. Brief Report: SETD2 Mutation in a Child with Autism, Intellectual Disabilities and Epilepsy.
Lumish HS; Wynn J; Devinsky O; Chung WK
J Autism Dev Disord; 2015 Nov; 45(11):3764-70. PubMed ID: 26084711
[TBL] [Abstract][Full Text] [Related]
8. De novo nonsense and frameshift variants of TCF20 in individuals with intellectual disability and postnatal overgrowth.
Schäfgen J; Cremer K; Becker J; Wieland T; Zink AM; Kim S; Windheuser IC; Kreiß M; Aretz S; Strom TM; Wieczorek D; Engels H
Eur J Hum Genet; 2016 Dec; 24(12):1739-1745. PubMed ID: 27436265
[TBL] [Abstract][Full Text] [Related]
9. Primary growth hormone (GH) insensitivity and insulin-like growth factor deficiency caused by novel compound heterozygous mutations of the GH receptor gene: genetic and functional studies of simple and compound heterozygous states.
Fang P; Riedl S; Amselem S; Pratt KL; Little BM; Haeusler G; Hwa V; Frisch H; Rosenfeld RG
J Clin Endocrinol Metab; 2007 Jun; 92(6):2223-31. PubMed ID: 17405847
[TBL] [Abstract][Full Text] [Related]
10. Growth hormone insensitivity syndrome associated with syringomyelia and type I Chiari malformation.
Takagi J; Otake K; Takahashi M; Nakao N; Hirooka Y; Sahashi K; Nogimori T
Intern Med; 2003 Nov; 42(11):1117-21. PubMed ID: 14686753
[TBL] [Abstract][Full Text] [Related]
11. A novel heterozygous STAT5B variant in a patient with short stature and partial growth hormone insensitivity (GHI).
Ramírez L; Sanguineti N; Scaglia P; Keselman A; Ballerini MG; Karabatas L; Landi E; Castro J; Domené S; Pennisi P; Jasper H; Rey RA; Vázquez M; Domené H; Bergadá I; Gutiérrez M
Growth Horm IGF Res; 2020 Feb; 50():61-70. PubMed ID: 31902742
[TBL] [Abstract][Full Text] [Related]
12. Pegvisomant therapy in pituitary gigantism: successful treatment in a 12-year-old girl.
Rix M; Laurberg P; Hoejberg AS; Brock-Jacobsen B
Eur J Endocrinol; 2005 Aug; 153(2):195-201. PubMed ID: 16061823
[TBL] [Abstract][Full Text] [Related]
13. Five-year follow-up of a 13-year-old boy with a pituitary adenoma causing gigantism--effect of octreotide therapy.
Schoof E; Dörr HG; Kiess W; Lüdecke DK; Freitag E; Zindel V; Rascher W; Dötsch J
Horm Res; 2004; 61(4):184-9. PubMed ID: 14739526
[TBL] [Abstract][Full Text] [Related]
14. Gps mutations in Chilean patients harboring growth hormone-secreting pituitary tumors.
Johnson MC; Codner E; Eggers M; Mosso L; Rodriguez JA; Cassorla F
J Pediatr Endocrinol Metab; 1999; 12(3):381-7. PubMed ID: 10821217
[TBL] [Abstract][Full Text] [Related]
15. A mutant signal transducer and activator of transcription 5b, associated with growth hormone insensitivity and insulin-like growth factor-I deficiency, cannot function as a signal transducer or transcription factor.
Fang P; Kofoed EM; Little BM; Wang X; Ross RJ; Frank SJ; Hwa V; Rosenfeld RG
J Clin Endocrinol Metab; 2006 Apr; 91(4):1526-34. PubMed ID: 16464942
[TBL] [Abstract][Full Text] [Related]
16. A novel truncating AIP mutation, p.W279*, in a familial isolated pituitary adenoma (FIPA) kindred.
Cansu GB; Taşkıran B; Trivellin G; Faucz FR; Stratakis CA
Hormones (Athens); 2016 Jul; 15(3):441-444. PubMed ID: 27838609
[TBL] [Abstract][Full Text] [Related]
17. [Growth Hormone-Insulin Growth Factor I (GH-IGF-I) axis and growth].
Castell AL; Sadoul JL; Bouvattier C
Ann Endocrinol (Paris); 2013 Oct; 74 Suppl 1():S33-41. PubMed ID: 24356290
[TBL] [Abstract][Full Text] [Related]
18. Cardiac and metabolic effects of chronic growth hormone and insulin-like growth factor I excess in young adults with pituitary gigantism.
Bondanelli M; Bonadonna S; Ambrosio MR; Doga M; Gola M; Onofri A; Zatelli MC; Giustina A; degli Uberti EC
Metabolism; 2005 Sep; 54(9):1174-80. PubMed ID: 16125529
[TBL] [Abstract][Full Text] [Related]
19. Growth hormone and insulin-like growth factor I insensitivity of fibroblasts isolated from a patient with an I{kappa}B{alpha} mutation.
Wu S; Walenkamp MJ; Lankester A; Bidlingmaier M; Wit JM; De Luca F
J Clin Endocrinol Metab; 2010 Mar; 95(3):1220-8. PubMed ID: 20080849
[TBL] [Abstract][Full Text] [Related]
20. Exome sequencing identifies a de novo SCN2A mutation in a patient with intractable seizures, severe intellectual disability, optic atrophy, muscular hypotonia, and brain abnormalities.
Baasch AL; Hüning I; Gilissen C; Klepper J; Veltman JA; Gillessen-Kaesbach G; Hoischen A; Lohmann K
Epilepsia; 2014 Apr; 55(4):e25-9. PubMed ID: 24579881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
